Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
300.78
-4.89 (-1.60%)
At close: Apr 22, 2026, 4:00 PM EDT
303.00
+2.22 (0.74%)
After-hours: Apr 22, 2026, 7:41 PM EDT
Bio-Rad Laboratories Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$339.75
Upside
+12.96%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $375 → $300 | Strong Buy → Hold | Downgrades | $375 → $300 | -0.26% | Apr 7, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $350 → $375 | Strong Buy | Maintains | $350 → $375 | +24.68% | Oct 30, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $265 → $340 | Hold | Maintains | $265 → $340 | +13.04% | Oct 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $387 → $409 | Buy | Maintains | $387 → $409 | +35.98% | Aug 1, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $245 → $265 | Hold | Maintains | $245 → $265 | -11.90% | Aug 1, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $260 → $245 | Hold | Maintains | $260 → $245 | -18.55% | Jun 9, 2025 |
| UBS | UBS | Strong Buy Maintains $355 → $310 | Strong Buy | Maintains | $355 → $310 | +3.07% | May 2, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $400 → $350 | Strong Buy | Maintains | $400 → $350 | +16.36% | May 2, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $409 → $392 | Buy | Maintains | $409 → $392 | +30.33% | May 2, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $320 → $270 | Hold | Maintains | $320 → $270 | -10.23% | Apr 17, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $430 → $409 | Buy | Maintains | $430 → $409 | +35.98% | Apr 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $450 → $400 | Strong Buy | Maintains | $450 → $400 | +32.99% | Mar 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $477 → $447 | Buy | Maintains | $477 → $447 | +48.61% | Feb 14, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $360 → $345 | Hold | Maintains | $360 → $345 | +14.70% | Feb 12, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $481 | Buy | Reiterates | $481 | +59.92% | Jan 14, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $369 → $481 | Buy | Maintains | $369 → $481 | +59.92% | Dec 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.